Orbactiv sales history revenue
WebSpecialties: Revenue Management, history & forecast analysis, salesmanship, talent development and training, sales training, reputation management, marketing, social media … WebInfusion Related Reactions: Administer ORBACTIV® over 3 hours to minimize infusion-related reactions. Infusion reactions characterized by chest pain, back pain, chills and tremor have been observed with the use of oritavancin products (e.g. ORBACTIV®), including after the administration of more than one dose of oritavancin during a single course
Orbactiv sales history revenue
Did you know?
WebSales Leadership & Product Market Growth - Increased Orbactiv utilization by 270 units in 2016 verses 2015 for an increase of $783k and total Orbactiv sales revenue of $2.1 million;... Web*INDICATION AND USAGE. Both KIMYRSA ® and ORBACTIV ® are oritavancin products that are indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus (including methicillin …
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin. The U.S. Food and Drug Administration (FDA) and … See more Oritavancin shares certain properties with other members of the glycopeptide class of antibiotics, which includes vancomycin, the current standard of care for serious Gram-positive infections in the United States and Europe. It … See more Oritavancin is active against gram-positive aerobic bacteria such as enterococci, staphylococci, streptococci, and anaerobic bacteria such as See more Originally discovered and developed by Eli Lilly, oritavancin was acquired by InterMune in 2001 and then by Targanta Therapeutics in … See more In 2003, results were presented from two pivotal phase-III clinical trials testing the efficacy of daily intravenous oritavancin for the treatment of acute bacterial skin and skin-structure infections (ABSSSI) caused by Gram-positive bacteria. The primary endpoints of … See more • "Oritavancin". Drug Information Portal. U.S. National Library of Medicine. See more WebSep 3, 2024 · The empirical formula of oritavancin diphosphate is C86H97N10O26Cl3•2H3PO4 and the molecular weight is 1989.09. ORBACTIV is supplied as a sterile white to off-white lyophilized powder for intravenous infusion that contains oritavancin diphosphate, mannitol (an inactive ingredient) and phosphoric acid (to adjust …
WebJun 23, 2016 · The company launched Orbactiv in the US market in October 2014. Other medications available in the market to treat ABSSSI include Dalvance (dalbavancin) developed by Durata Therapeutics and Sivextro developed by Cubist Pharmaceuticals. WebOrbactiv Sales Medicare Prescription Data PharmaCompass.com. Filters. Reset Filter. Price Info. Product Main Page. U.S. MEDICAID PRESCRIPTIONS. Upload your Marketing & …
WebFeb 20, 2014 · Orbactiv FDA Approval History. FDA Approved: Yes (First approved August 6, 2014) Brand name: Orbactiv Generic name: oritavancin Dosage form: Injection Company: The Medicines Company Treatment for: Skin and Structure Infection Orbactiv (oritavancin) is a semi-synthetic lipoglycopeptide antibiotic for the treatment of acute bacterial skin and …
WebExperienced sales leader with a demonstrated history in the hospitality industry providing exceptional customer service. Skilled in Destination Management, Food & Beverage, Hotel … rbi circular on payment gatewayWebNov 29, 2024 · U.S. combined net sales of Minocin IV and Orbactiv On net sales at or below $100 million = 5.0% On net sales above $100 million = 15.0% Ex-U.S. combined net sales … rbi circular on ind as for nbfcsWeb2.2 Preparation of ORBACTIV for Intravenous Infusion . ORBACTIV is intended for intravenous infusion, only after reconstitution and dilution. Three ORBACTIV 400 mg vials need to be reconstituted and diluted to prepare a single 1200 mg intravenous dose. Reconstitution: Aseptic technique should be used to reconstitute three ORBACTIV 400 mg … sims 4 cc sleeveless crop topWebORBACTIV® (oritavancin): The first. Single dose. regimen for treating ABSSSI. A single 1200 mg infusion helps ensure adherence to a full course of therapy. * Mild renal impairment creatine clearance (CrCl) 50-79 mL/min, moderate renal impairment CrCl 30-49 mL/min. † Moderate hepatic impairment (Child-Pugh Class B). rbi circular on money market instrumentsWebSales history aids analysts in determining current sales trends and identifying patterns of buying behaviour or revenue cycles. One or more of the following can be used to identify these trends: 1. The kind of product 2. Sales territory 3. The time of year 4. Customer groups (by gender, age, occupation, and so on) sims 4 cc star pimple patchWebHeadquarters United States Website www.orbactiv.com Revenue <$5M Is this data correct? Popular Searches Orbactiv SIC Code 28,283 NAICS Code 32,325 Show More Top … rbi circular on payment of dividendWebFeb 22, 2024 · Orbactiv (oritavancin) for injection is an antibiotic used to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram -positive microorganisms: Staphylococcus aureus (including methicillin -susceptible and methicillin-resistant isolates), Streptococcus pyogenes, … sims 4 cc split hair